Advertisement
Advertisement
LFMD
LifeMD, Inc. Common Stock
3.90
USDSponsored
+0.02
+0.64%
Mar 25, 15:59 UTC -4
Closed
Pre-Market
3.85
-0.05
-1.21%
LFMD Earnings Reports
Positive Surprise Ratio
LFMD beat 7 of 21 last estimates.
33%
Next Report
Date of Next Report
May 04, 2026
Estimate for Q1 26 (Revenue/ EPS)
$49.54M
/-$0.15
Implied change from Q4 25 (Revenue/ EPS)
+5.70%
/+275.00%
Implied change from Q1 25 (Revenue/ EPS)
-24.60%
/-1600.00%
LifeMD, Inc. Common Stock earnings per share and revenue
On Mar 09, 2026, LFMD reported earnings of -0.04 USD per share (EPS) for Q4 25, missing the estimate of -0.03 USD, resulting in a -17.65% surprise. Revenue reached 46.87 million, compared to an expected 47.78 million, with a -1.92% difference. The market reacted with a +25.32% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 9 analysts forecast an EPS of -0.15 USD, with revenue projected to reach 49.54 million USD, implying an increase of 275.00% EPS, and increase of 5.70% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
The Oncology Institute, Inc. Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.09
Actual
-$0.06
Surprise
+33.99%
The Beauty Health Company Class A Common Stock
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.06
Surprise
-14.29%
Sera Prognostics, Inc. Class A Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.19
Actual
-$0.16
Surprise
+17.44%
DocGo Inc. Common Stock
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.13
Actual
-$1.37
Surprise
-920.10%
HealthEquity, Inc
Report Date
Mar 17, 2026 For Q4 26
Estimate
$0.90
Actual
$0.95
Surprise
+4.51%
IceCure Medical Ltd. Ordinary Shares
Report Date
Mar 17, 2026 For Q4 25
Estimate
-$0.04
Actual
-$0.07
Surprise
-52.51%
Lifeward Ltd. Ordinary Shares
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$1.10
Actual
-$3.60
Surprise
-226.80%
SeaStar Medical Holding Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$1.07
Actual
-$0.80
Surprise
+25.28%
Healthy Choice Wellness Corp.
Report Date
Mar 16, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.05
Surprise
+1.96%
Aclarion, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$3.67
Actual
-$2.54
Surprise
+30.83%
FAQ
What were LifeMD, Inc. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, LifeMD, Inc. Common Stock reported EPS of -$0.04, missing estimates by -17.65%, and revenue of $46.87M, -1.92% below expectations.
How did the market react to LifeMD, Inc. Common Stock's Q4 2025 earnings?
The stock price moved up 25.32%, changed from $3.12 before the earnings release to $3.91 the day after.
When is LifeMD, Inc. Common Stock expected to report next?
The next earning report is scheduled for May 04, 2026.
What are the forecasts for LifeMD, Inc. Common Stock's next earnings report?
Based on 9
analysts, LifeMD, Inc. Common Stock is expected to report EPS of -$0.15 and revenue of $49.54M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement